CVS Health stock is trading -17.35% below its average target price of $67.56 after dropping -2.2% during today's afternoon session. Analysts are giving the Large-Cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $60.0 to $91.12 per share.
The stock has a very low short interest at 1.7%, and a short ratio of 1.84. The company's insiders own 0.12% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 82.8% of CVS Health's shares being owned by this investor type.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-06-30 | Vanguard Group Inc | 9% | 116,350,122 | $6,497,002,370 |
| 2024-06-30 | Blackrock Inc. | 8% | 100,151,218 | $5,592,453,961 |
| 2024-06-30 | Dodge & Cox Inc | 5% | 61,683,343 | $3,444,404,000 |
| 2024-06-30 | Capital World Investors | 4% | 56,023,849 | $3,128,377,293 |
| 2024-06-30 | State Street Corporation | 4% | 54,538,843 | $3,045,454,410 |
| 2024-06-30 | Capital Research Global Investors | 3% | 35,455,509 | $1,979,839,144 |
| 2024-06-30 | FMR, LLC | 2% | 29,371,944 | $1,640,132,270 |
| 2024-06-30 | Geode Capital Management, LLC | 2% | 25,900,104 | $1,446,264,380 |
| 2024-06-30 | Morgan Stanley | 2% | 22,860,551 | $1,276,535,438 |
| 2024-06-30 | Capital International Investors | 2% | 20,737,675 | $1,157,993,831 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on CVS Health.
